All Things ETF

Out looking for new products today. Guggenheim Investments has a new class of ETFs called Pure Style ETFs .  The funds are based on the concept that the, "potential drawback of actively managed mutual funds and traditional cap‐weighted style indices is a lack of style purity. This may undermine portfolio optimization and Guggenheim Pure Style ETFs seek to address this shortcoming with a unique approach, offering only “pure” exposure to value and growth investing."   Guggenheim lists about 7 funds in this new class of funds. If you would like more information on how this class of funds can help you grow you wealth, call us at 1-866-801-3359 or visit our website at UCS Financial Advisors and fill out and submit the secured form on our Wealth Products page requesting more information in the comments section of the form. **Please note we are in no way affiliated with Guggenheim Investments or any of its funds or investments, nor are we paid to recommend a...

The ProShares Technology Fund traded briskly again in the last few hours of the trading day. Volume was a little over 199,900 shares. I got a good strong buy signal on the fund today at a share price of $32.08, my desired entry point, instead I got greedy and decided to wait for a better price. WRONG! Fund price consolidated and headed higher for a high of $33.00. Greed is not good! I will try again tomorrow. On another note, I've added the iShares Pharmaceutical Fund to our daily watch list. I am not to keen on the iShares etf products because they have performed so horribly. However, since the entire portfolio was sold to CVC Capital Partners for $4.4 billion, I believe the funds maybe making a comeback, a performance comeback I mean. Volume was almost non-existent on the iShares Pharmaceutical Fund, with under 25,000 shares traded today. I am not sure if I should recommend shorting this fund or buying it. I guess that's why its on the watch list. 06/09/09 09:03 PM